These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16229996)

  • 1. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural allergens and recombinant allergens].
    Deviller P
    Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant allergens for diagnosis and specific immunotherapy--value in pediatric patients].
    Couderc R; Just J
    Bull Acad Natl Med; 2013 Mar; 197(3):645-59; discussion 659-60. PubMed ID: 25163347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering and validation of recombinant proteins for allergen vaccines.
    Spangfort MD
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):151-4; discussion 155. PubMed ID: 15119033
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.
    Cromwell O; Fiebig H; Suck R; Kahlert H; Nandy A; Kettner J; Narkus A
    Immunol Allergy Clin North Am; 2006 May; 26(2):261-81, vii. PubMed ID: 16701144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches for new vaccines against allergy.
    Niederberger V; Valenta R
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarrays: molecular allergology and nanotechnology for personalised medicine (I).
    Lucas JM
    Allergol Immunopathol (Madr); 2010; 38(3):153-61. PubMed ID: 20398997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
    Tscheppe A; Breiteneder H
    Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically modified allergens.
    Niederberger V; Valenta R
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):727-38. PubMed ID: 15474868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant allergens for immunotherapy.
    Chapman MD; Smith AM; Vailes LD; Pomés A
    Allergy Asthma Proc; 2002; 23(1):5-8. PubMed ID: 11894735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.